Investigational agent could help manage postoperative pain without the use of opioids
Real-world evidence, from a multi-center postoperative pain management study, has shown that the investigational agent, HTX-011, could be a key tool in helping reduce opioid prescriptions after surgery.
Please sign in or register for FREE
Sign in to The Evidence Base
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>